Building Medtech Connections and Why They Matter
Scott Whitaker, president and CEO of AdvaMed, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of…
Investor Relations
AdvaMed’s Top 10 Medtech Wins in 2022
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a…
AdvaMed Concludes Record-Breaking The Medtech Conference 2022
The Advanced Medical Technology Association (AdvaMed) this week concluded its annual The Medtech Conference, a content-packed three days in a return to fully in-person events. The Medtech Conference, regarded as…
AdvaMed Champions Congressional Reauthorization of Vital Small Business Investment Programs
This week, the Senate and House unanimously approved the reauthorization of the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs for three years. Since early 2021, AdvaMed…
Medtech Investment Working Group – Q3 Meeting
AdvaMed Accel held the 3rd Quarter meeting of the Medtech Investment Working Group.
New Episode of Medtech POV Podcast: Vibrato CEO Calls for Reauthorization of the Federal Small Business Innovation Funding Program
Juliana Elstad, President and CEO of Vibrato Medical, recently joined AdvaMed’s Scott Whitaker on The Medtech POV podcast for a conversation on several policy initiatives.
Managing Your Life Sciences Portfolio: False Claims Act Risk for Private Investors and How AdvaMed Can Help
In recent years, private investors have been subject to increased government enforcement scrutiny under the False Claims Act. Given investors’ vital role in medtech, AdvaMed developed tools and resources to…
Medtech Investment Working Group – Q2 Meeting
AdvaMed Accel held the 2nd Quarter meeting of the Medtech Investment Working Group.
New for Upcoming Medtech Conference: AdvaMed Announces Investor Forum, Including Session with Chief Executives for Corporate Purpose
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association (AdvaMed) released this statement from President and CEO Scott Whitaker.